Cargando…
Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
We used the eXtreme Gradient Boosting algorithm, an optimized gradient boosting machine learning library, and established a model to predict events in Philadelphia chromosome-positive acute lymphoblastic leukemia using a machine learning-aided method. A model was constructed using a training set (80...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890949/ https://www.ncbi.nlm.nih.gov/pubmed/33602341 http://dx.doi.org/10.1186/s40364-021-00268-x |
_version_ | 1783652601713131520 |
---|---|
author | Nishiwaki, Satoshi Sugiura, Isamu Koyama, Daisuke Ozawa, Yukiyasu Osaki, Masahide Ishikawa, Yuichi Kiyoi, Hitoshi |
author_facet | Nishiwaki, Satoshi Sugiura, Isamu Koyama, Daisuke Ozawa, Yukiyasu Osaki, Masahide Ishikawa, Yuichi Kiyoi, Hitoshi |
author_sort | Nishiwaki, Satoshi |
collection | PubMed |
description | We used the eXtreme Gradient Boosting algorithm, an optimized gradient boosting machine learning library, and established a model to predict events in Philadelphia chromosome-positive acute lymphoblastic leukemia using a machine learning-aided method. A model was constructed using a training set (80%) and prediction was tested using a test set (20%). According to the feature importance score, BCR-ABL lineage, polymerase chain reaction value, age, and white blood cell count were identified as important features. These features were also confirmed by the permutation feature importance for the prediction using the test set. Both event-free survival and overall survival were clearly stratified according to risk groups categorized using these features: 80 and 100% in low risk (two or less factors), 42 and 47% in intermediate risk (three factors), and 0 and 10% in high risk (four factors) at 4 years. Machine learning-aided analysis was able to identify clinically useful prognostic factors using data from a relatively small number of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-021-00268-x. |
format | Online Article Text |
id | pubmed-7890949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78909492021-02-22 Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia Nishiwaki, Satoshi Sugiura, Isamu Koyama, Daisuke Ozawa, Yukiyasu Osaki, Masahide Ishikawa, Yuichi Kiyoi, Hitoshi Biomark Res Letter to the Editor We used the eXtreme Gradient Boosting algorithm, an optimized gradient boosting machine learning library, and established a model to predict events in Philadelphia chromosome-positive acute lymphoblastic leukemia using a machine learning-aided method. A model was constructed using a training set (80%) and prediction was tested using a test set (20%). According to the feature importance score, BCR-ABL lineage, polymerase chain reaction value, age, and white blood cell count were identified as important features. These features were also confirmed by the permutation feature importance for the prediction using the test set. Both event-free survival and overall survival were clearly stratified according to risk groups categorized using these features: 80 and 100% in low risk (two or less factors), 42 and 47% in intermediate risk (three factors), and 0 and 10% in high risk (four factors) at 4 years. Machine learning-aided analysis was able to identify clinically useful prognostic factors using data from a relatively small number of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-021-00268-x. BioMed Central 2021-02-18 /pmc/articles/PMC7890949/ /pubmed/33602341 http://dx.doi.org/10.1186/s40364-021-00268-x Text en © The Author(s) 2021, corrected publication March 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Nishiwaki, Satoshi Sugiura, Isamu Koyama, Daisuke Ozawa, Yukiyasu Osaki, Masahide Ishikawa, Yuichi Kiyoi, Hitoshi Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title | Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title_full | Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title_fullStr | Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title_full_unstemmed | Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title_short | Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia |
title_sort | machine learning-aided risk stratification in philadelphia chromosome-positive acute lymphoblastic leukemia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890949/ https://www.ncbi.nlm.nih.gov/pubmed/33602341 http://dx.doi.org/10.1186/s40364-021-00268-x |
work_keys_str_mv | AT nishiwakisatoshi machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT sugiuraisamu machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT koyamadaisuke machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT ozawayukiyasu machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT osakimasahide machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT ishikawayuichi machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia AT kiyoihitoshi machinelearningaidedriskstratificationinphiladelphiachromosomepositiveacutelymphoblasticleukemia |